198 related articles for article (PubMed ID: 28663027)
1. Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study.
Misdrahi D; Tessier A; Husky M; Lange AC; Vrijens B; Llorca PM; Baylé FJ
Schizophr Res; 2018 Mar; 193():114-118. PubMed ID: 28663027
[TBL] [Abstract][Full Text] [Related]
2. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic treatment dosing profile in patients with schizophrenia evaluated with electronic monitoring (MEMS®).
Acosta FJ; Ramallo-Fariña Y; Bosch E; Mayans T; Rodríguez CJ; Caravaca A
Schizophr Res; 2013 May; 146(1-3):196-200. PubMed ID: 23474024
[TBL] [Abstract][Full Text] [Related]
4. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
[TBL] [Abstract][Full Text] [Related]
5. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
6. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
[TBL] [Abstract][Full Text] [Related]
7. Brief interventions for improving adherence in schizophrenia: A pilot study using electronic medication event monitoring.
Tessier A; Dupuy M; Baylé FJ; Herse C; Lange AC; Vrijens B; Schweitzer P; Swendsen J; Misdrahi D
Psychiatry Res; 2020 Mar; 285():112780. PubMed ID: 31954541
[TBL] [Abstract][Full Text] [Related]
8. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
9. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
10. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia.
Byerly M; Fisher R; Whatley K; Holland R; Varghese F; Carmody T; Magouirk B; Rush AJ
Psychiatry Res; 2005 Feb; 133(2-3):129-33. PubMed ID: 15740989
[TBL] [Abstract][Full Text] [Related]
11. Stigma, discrimination and medication adherence in schizophrenia: results from the Swedish COAST study.
Brain C; Sameby B; Allerby K; Quinlan P; Joas E; Lindström E; Burns T; Waern M
Psychiatry Res; 2014 Dec; 220(3):811-7. PubMed ID: 25457284
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables.
Acosta FJ; Bosch E; Sarmiento G; Juanes N; Caballero-Hidalgo A; Mayans T
Schizophr Res; 2009 Feb; 107(2-3):213-7. PubMed ID: 18849150
[TBL] [Abstract][Full Text] [Related]
13. Medication-taking behaviours in young adults with schizophrenia: a pilot study.
Lee H; Kane I; Sereika SM; Cho RY; Jolley CJ
J Psychiatr Ment Health Nurs; 2011 Jun; 18(5):418-24. PubMed ID: 21539687
[TBL] [Abstract][Full Text] [Related]
14. Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder.
Dunn KE; King VL; Brooner RK
Drug Alcohol Depend; 2016 Mar; 160():212-7. PubMed ID: 26851987
[TBL] [Abstract][Full Text] [Related]
15. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
[TBL] [Abstract][Full Text] [Related]
16. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
17. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
McCann TV; Clark E; Lu S
J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between medication adherence and rehospitalization: a prospective study of schizophrenia patients discharged from psychiatric acute wards].
Shao WC; Chen H; Chang YF; Lin WC; Lin EC
Hu Li Za Zhi; 2013 Oct; 60(5):31-40. PubMed ID: 24096463
[TBL] [Abstract][Full Text] [Related]
19. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
[TBL] [Abstract][Full Text] [Related]
20. Adherence to clozapine vs. other antipsychotics in schizophrenia.
Takeuchi H; Borlido C; Sanches M; Teo C; Harber L; Agid O; Remington G
Acta Psychiatr Scand; 2020 Aug; 142(2):87-95. PubMed ID: 32627168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
